Petros Pharmaceuticals Inc (PTPI)
NASDAQ
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -111.404 | -32.11 | -13.096 | -40.152 | -41.723 |
Return on Equity (%) | -810.849 | -161.535 | -33.904 | -76.705 | -96.021 |
Return on Invested Capital (%) | -355.222 | -237.031 | -72.501 | -30.866 | -58.878 |
Operating Margin (%) | -123.978 | -198.378 | -110.332 | -324.466 | -131.003 |
Net Profit Margin (%) | -208.712 | -215.357 | -115.056 | -334.413 | -237.272 |
Book Value Per Share | -8.964 | -1.513 | 0.496 | 0.215 | 1.655 |
Earnings Per Share | -9.465 | -2.121 | -0.434 | -0.968 | -6.516 |
Cash Per Share | 0.625 | 1.766 | 1.153 | 0.455 | 6.291 |
Working Capital Per Share | -8.447 | -1.647 | -0.021 | 0.367 | 4.537 |
Operating Profit Per Share | 2.373 | 0.568 | 0.3 | 0.342 | 1.977 |
EBIT Per Share | -9.653 | -2.268 | -0.434 | -0.968 | -3.85 |
EBITDA Per Share | -9.653 | -2.268 | -0.434 | -0.968 | -3.85 |
Free Cash Flow Per Share | -10.984 | -2.806 | -0.767 | -1.238 | -8.065 |
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 3,44M | 9,71M | 20,69M | N/A | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
Actions en circulation | N/A | 2,09M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -49.365 | N/A | N/A | N/A | -147.084 | N/A | N/A |
Net Profit Margin (%) | N/A | -55.004 | N/A | N/A | N/A | -577.898 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 3,96M |
Ratio cours/bénéfice | -0,3 |
Ratio prix/ventes | 0,72 |
Ratio prix/liquidités | 0,32 |
Ratio prix/valeur comptable | 0,34 |
Rendement de dividende | - |
Actions en circulation | 10,01M |
Volume moyen (1 semaine) | 1,16M |
Volume moyen (1 mois) | 5,16M |
Variation sur 52 semaines | -68,90% |
Plus haut sur 52 semaines | 2,27 |
Plus bas sur 52 semaines | 0,2208 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales